I agree that this site is using cookies. You can find further informations here.
X
Elizabeth Dudnik
104  results:
Search for persons X
?
1

Mobocertinib in Patients with EGFR Exon 20 Insertion-Positi..:

Illini, Oliver ; Saalfeld, Felix Carl ; Christopoulos, Petros...
International Journal of Molecular Sciences.  25 (2024)  7 - p. 3992 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Neoadjuvant Osimertinib Followed by Sequential Definitive R..:

Peled, Nir ; Roisman, Laila C. ; Levison, Esther...
International Journal of Radiation Oncology*Biology*Physics.  117 (2023)  1 - p. 105-114 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Arterial and Venous Thromboembolism in ALK-Rearrangement-Po..:

Icht, Oded ; Leader, Avi ; Batat, Erez...
The Oncologist.  28 (2023)  6 - p. e391-e396 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Correlations between pathogenic variants in DNA repair gene..:

Averbuch, Itamar ; Tschernichovsky, Roi ; Icht, Oded...
Thoracic Cancer.  14 (2023)  17 - p. 1589-1596 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Blood-Derived Exosomal hTERT mRNA in Patients with Lung Can..:

Rotem, Ofer ; Zer, Alona ; Yosef, Lilach...
Biomedicines.  11 (2023)  6 - p. 1730 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Real-world experience with capmatinib in MET exon 14-mutate..:

Illini, Oliver ; Fabikan, Hannah ; Swalduz, Aurélie...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592211032 , 2022
Link: https://doi.org/10.1177/..
 
?
7

dNLR-Based Score Predicting Overall Survival Benefit for Th..:

Holtzman, Liran ; Moskovitz, Mor ; Urban, Damien...
Clinical Lung Cancer.  23 (2022)  2 - p. 122-134 , 2022
Link: https://doi.org/10.1016/..
 
?
8

FGFR Fusions as an Acquired Resistance Mechanism Following ..:

Raphael, Ari ; Dudnik, Elizabeth ; Hershkovitz, Dov...
Journal of Clinical Medicine.  11 (2022)  9 - p. 2475 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Real-world efficacy and safety of mobocertinib in EGFR exon..:

Kian, Waleed ; Christopoulos, Petros ; Remilah, Areen A....
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

ALK Inhibitors or Chemotherapy for Third Line in ALK-positi..:

Moskovitz, Mor ; Dudnik, Elizabeth ; Shamai, Sivan...
The Oncologist.  27 (2022)  1 - p. e76-e84 , 2022
Link: https://doi.org/10.1093/..
 
?
11

The Impact of Comprehensive Genomic Profiling (CGP) on the ..:

Raphael, Ari ; Onn, Amir ; Holtzman, Liran...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
12

Height in adolescence as a risk factor for glioma subtypes:..:

Tschernichovsky, Roi ; Katz, Lior H ; Derazne, Estela...
Neuro-Oncology.  23 (2021)  8 - p. 1383-1392 , 2021
Link: https://doi.org/10.1093/..
 
?
13

Treatment patterns, testing practices, and outcomes in the ..:

Addeo, Alfredo ; Hochmair, Maximilian ; Janzic, Urska...
Therapeutic Advances in Medical Oncology.  13 (2021)  - p. 175883592110598 , 2021
Link: https://doi.org/10.1177/..
 
?
14

BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With ..:

Dudnik, Elizabeth ; Bar, Jair ; Moore, Assaf...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

Osimertinib in advanced EGFR-mutant lung adenocarcinoma wit..:

Peled, Nir ; Kian, Waleed ; Inbar, Edna...
Neuro-Oncology Advances.  4 (2021)  1 - p. , 2021
Link: https://doi.org/10.1093/..
 
1-15